Outlook Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.43

+0.04 (+10.10%)

As of Feb 8, 2:22 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 7 64%

Hold 4 36%

Sell 0 0%

Price Target

Analyst Price Target +7,999.7% upside

Low Target $27.07

Average Target $34.78

High Target $51.13

Current Price $0.43

Current
$0.43

Target
$34.78

$27.07 $34.78 avg $51.13

Scenario Analysis

Bear Case

$27.07

6,204.1%

Low target

Base Case

$34.78

+7,999.7%

Avg target

Bull Case

$51.13

+11,807.3%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$32.88

-98.7% from high

52-Week Low

$24.50

+-98.2% from low

Target vs 52W High

$34.78

+5.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%